SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs
Crossref DOI link: https://doi.org/10.1038/s41401-023-01221-4
Published Online: 2024-01-10
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Wen-jing
Xie, Cheng-ying
Zhu, Xi
Tang, Jiao
Wang, Lei
Lou, Li-guang
Text and Data Mining valid from 2024-01-10
Version of Record valid from 2024-01-10
Article History
Received: 17 August 2023
Accepted: 19 December 2023
First Online: 10 January 2024
Competing interests
: The authors declare no competing interests.